{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:30:59Z","timestamp":1773873059803,"version":"3.50.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Taighde \u00c9ireann - Research Ireland","doi-asserted-by":"publisher","award":["21\/FFP-P\/10130"],"award-info":[{"award-number":["21\/FFP-P\/10130"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024932","name":"Children\u2019s Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024932","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000672","name":"Pathological Society of Great Britain and Ireland","doi-asserted-by":"publisher","award":["TSGS 0425 03"],"award-info":[{"award-number":["TSGS 0425 03"]}],"id":[{"id":"10.13039\/501100000672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.tranon.2025.102611","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T03:57:29Z","timestamp":1764043049000},"page":"102611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and molecular variations in Burkitt lymphoma"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-5453","authenticated-orcid":false,"given":"Eoghan","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8835-2347","authenticated-orcid":false,"given":"Patricia","family":"Scanlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen Patrick","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-9630","authenticated-orcid":false,"given":"Melinda","family":"Halasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0001","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2141.2012.09027.x","article-title":"Burkitt lymphoma in Uganda, the legacy of Denis Burkitt and an update on the disease status","volume":"156","author":"Walusansa","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0002","first-page":"211","article-title":"A lymphoma syndrome in African children","volume":"30","author":"Burkitt","year":"1962","journal-title":"Ann. R. Coll. Surg. Engl."},{"issue":"16","key":"10.1016\/j.tranon.2025.102611_bib0003","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/bloodadvances.2020002178","article-title":"Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa","volume":"4","author":"Ozuah","year":"2020","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.beha.2018.07.013","article-title":"Burkitt lymphoma- a rare but challenging lymphoma","volume":"31","author":"Casulo","year":"2018","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"9822","key":"10.1016\/j.tranon.2025.102611_bib0005","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.tranon.2025.102611_bib0006","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1080\/10428194.2020.1747068","article-title":"Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy","volume":"61","author":"Zayac","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"19","key":"10.1016\/j.tranon.2025.102611_bib0007","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.tranon.2025.102611_bib0008","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1158\/1541-7786.MCR-16-0305","article-title":"Comprehensive transcriptome and mutational profiling of endemic burkitt lymphoma reveals EBV type-specific differences","volume":"15","author":"Kaymaz","year":"2017","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0009","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjh.17874","article-title":"Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features","volume":"196","author":"Richter","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.tranon.2025.102611_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005158","article-title":"Distinct viral and mutational spectrum of endemic burkitt lymphoma","volume":"11","author":"Abate","year":"2015","journal-title":"PLoS. Pathog."},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0011","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0012","first-page":"1397","article-title":"Epstein-Barr virus and Burkitt lymphoma","volume":"60","author":"Brady","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0013","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13244-019-0733-7","article-title":"An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence","volume":"10","author":"Kalisz","year":"2019","journal-title":"Insights. ImAging"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0014","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ajh.23385","article-title":"Burkitt lymphoma risk in U.S. solid organ transplant recipients","volume":"88","author":"Mbulaiteye","year":"2013","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.tranon.2025.102611_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000332","article-title":"Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?","volume":"39","author":"Satou","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0016","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bjh.17922","article-title":"Epstein-Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes","volume":"196","author":"Leoncini","year":"2022","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102611_bib0017","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0018","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41375-022-01764-1","article-title":"A comparison of the international consensus and 5th world health organization classifications of mature B-cell lymphomas","volume":"37","author":"Falini","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0019","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pbc.22047","article-title":"Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005","volume":"53","author":"Mbulaiteye","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0021","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semcancer.2009.07.007","article-title":"How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?","volume":"19","author":"Allday","year":"2009","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13027-022-00452-0","article-title":"Epstein-Barr virus and Burkitt\u2019s lymphoma. associations in Iraqi Kurdistan and twenty-two countries assessed in the International Incidence of childhood cancer","volume":"17","author":"Muhealdeen","year":"2022","journal-title":"Infect. Agents Cancer"},{"issue":"24","key":"10.1016\/j.tranon.2025.102611_bib0023","first-page":"16","article-title":"The functional interaction between Epstein-Barr Virus and MYC in the pathogenesis of Burkitt lymphoma","author":"Solares","year":"2024","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.tranon.2025.102611_bib0024","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ebiom.2016.11.034","article-title":"Parasite infection, carcinogenesis and Human malignancy","volume":"15","author":"van Tong","year":"2017","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2741\/3982","article-title":"Understanding TLR9 action in Epstein-Barr virus infection","volume":"17","author":"Zauner","year":"2012","journal-title":"Front. Biosci. (Landmark. Ed)"},{"issue":"5","key":"10.1016\/j.tranon.2025.102611_bib0026","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/s41418-019-0435-1","article-title":"EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins","volume":"27","author":"Fitzsimmons","year":"2020","journal-title":"Cell Death. Differ."},{"issue":"5","key":"10.1016\/j.tranon.2025.102611_bib0027","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1128\/JVI.03003-12","article-title":"Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature","volume":"87","author":"Kelly","year":"2013","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102611_bib0028","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990\u20132017","volume":"10","author":"Gulfaraz","year":"2020","journal-title":"BMJ Open."},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0029","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27399","article-title":"Burkitt lymphoma in Iraqi children: a distinctive form of sporadic disease with high incidence of EBV(+) cases and more frequent expression of MUM1\/IRF4 protein in cases with head and neck presentation","volume":"65","author":"Uccini","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/08880018.2020.1865493","article-title":"Clinical profile, outcome and challenges in the management of pediatric Burkitt lymphoma: a single center experience","volume":"38","author":"Chauhan","year":"2021","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0031","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/0366-6999.151106","article-title":"Clinicopathological study of sporadic Burkitt lymphoma in children","volume":"128","author":"Huang","year":"2015","journal-title":"Chin. Med. J. (Engl)"},{"issue":"18","key":"10.1016\/j.tranon.2025.102611_bib0032","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.ejca.2004.09.004","article-title":"Gender and age-related differences in Burkitt lymphoma\u2013epidemiological and clinical data from The Netherlands","volume":"40","author":"Boerma","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0033","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1309\/AJCP64YOHAWLUMPK","article-title":"Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features","volume":"130","author":"Queiroga","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099857","article-title":"Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence","volume":"9","author":"Xiong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2025.102611_bib0035","first-page":"1","article-title":"Non-hodgkin lymphoma in the Middle East is characterized by low incidence rates with advancing age","volume":"5","author":"Yaqo","year":"2019","journal-title":"J. Glob. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0036","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/PPO.0000000000000448","article-title":"HIV lymphoma and Burkitts lymphoma","volume":"26","author":"Noy","year":"2020","journal-title":"Cancer J."},{"key":"10.1016\/j.tranon.2025.102611_bib0037","doi-asserted-by":"crossref","DOI":"10.21037\/aol-21-18","article-title":"Reframing Burkitt lymphoma: virology not epidemiology defines clinical variants","volume":"5","author":"Rochford","year":"2021","journal-title":"Ann. Lymphoma"},{"key":"10.1016\/j.tranon.2025.102611_bib0038","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1746-1596-7-72","article-title":"Sporadic Burkitt lymphomas of children and adolescents in Chinese: a clinicopathological study of 43 cases","volume":"7","author":"Bi","year":"2012","journal-title":"Diagn. Pathol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102611_bib0039","first-page":"S78","article-title":"Clinical characteristics of Burkitt's lymphoma seen in Kenyan patients","author":"Mwanda","year":"2004","journal-title":"East Afr. Med. J."},{"issue":"9","key":"10.1016\/j.tranon.2025.102611_bib0040","first-page":"S135","article-title":"Clinical characteristics of Burkitt's lymphoma from three regions in Kenya","volume":"82","author":"Mwanda","year":"2005","journal-title":"East Afr. Med. J."},{"issue":"10","key":"10.1016\/j.tranon.2025.102611_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27275","article-title":"The changing clinical pattern of endemic Burkitt lymphoma in Western Africa: experience from a tertiary center in Ghana","volume":"65","author":"Offor","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0042","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.trstmh.2011.08.008","article-title":"Clinical characteristics, treatment and outcome of childhood Burkitt's lymphoma at the Uganda Cancer Institute","volume":"105","author":"Orem","year":"2011","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"11","key":"10.1016\/j.tranon.2025.102611_bib0043","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/ijc.23800","article-title":"Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited","volume":"123","author":"Ogwang","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2025.102611_bib0044","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014282","article-title":"Oncogenic mechanisms in Burkitt lymphoma","volume":"4","author":"Schmitz","year":"2014","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"issue":"7418","key":"10.1016\/j.tranon.2025.102611_bib0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0046","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/imr.12755","article-title":"Germinal center-derived lymphomas: the darkest side of humoral immunity","volume":"288","author":"Mlynarczyk","year":"2019","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0047","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.tranon.2025.102611_bib0048","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1732","key":"10.1016\/j.tranon.2025.102611_bib0049","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0271","article-title":"Epstein-Barr virus-associated lymphomas","volume":"372","author":"Shannon-Lowe","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1073\/pnas.2237267100","article-title":"Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo","volume":"101","author":"Hochberg","year":"2004","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-005-0036-x","article-title":"Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells","volume":"132","author":"Hong","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0052","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bjh.14744","article-title":"Aggressive B-cell lymphomas in the update of the 4th edition of the World Health Organization classification of haematopoietic and lymphatic tissues: refinements of the classification, new entities and genetic findings","volume":"178","author":"Ott","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/genes8040116","article-title":"The role of c-MYC in B-cell lymphomas: diagnostic and molecular aspects","volume":"8","author":"Nguyen","year":"2017","journal-title":"Genes. (Basel)"},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0054","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2025.102611_bib0055","first-page":"27","article-title":"Developments in Burkitt's lymphoma: novel cooperations in oncogenic MYC signaling","volume":"6","author":"Spender","year":"2014","journal-title":"Cancer Manage Res."},{"issue":"50","key":"10.1016\/j.tranon.2025.102611_bib0056","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1038\/onc.2008.312","article-title":"Apoptotic signaling by c-MYC","volume":"27","author":"Hoffman","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0057","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3324\/haematol.2016.156885","article-title":"Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-hodgkin Lymphoma Berlin-Frankfurt-M\u00fcnster protocols","volume":"102","author":"Rohde","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.tranon.2025.102611_bib0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-Barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu Rev. Pathol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102611_bib0059","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-020-00446-2","article-title":"Transcriptional regulation of memory B cell differentiation","volume":"21","author":"Laidlaw","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"20","key":"10.1016\/j.tranon.2025.102611_bib0061","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.tranon.2025.102611_bib0062","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2012.06.012","article-title":"Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis","volume":"22","author":"Sander","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0063","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"L\u00f3pez","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.tranon.2025.102611_bib0064","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a014407","article-title":"MYC and the control of apoptosis","volume":"4","author":"McMahon","year":"2014","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0065","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.tranon.2025.102611_bib0066","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","author":"Thomas","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0067","first-page":"672","article-title":"EBNA1 Upregulates P53-inhibiting genes in Burkitt's Lymphoma Cell Line","volume":"11","author":"Hashemi","year":"2023","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.tranon.2025.102611_bib0068","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0069","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.cdd.4401925","article-title":"The complexity of p53 stabilization and activation","volume":"13","author":"Lavin","year":"2006","journal-title":"Cell Death Differ."},{"issue":"5","key":"10.1016\/j.tranon.2025.102611_bib0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","article-title":"Role of genetic and epigenetic changes in Burkitt lymphoma","volume":"12","author":"Lindstr\u00f6m","year":"2002","journal-title":"Semin. Cancer Biol."},{"issue":"20","key":"10.1016\/j.tranon.2025.102611_bib0071","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"issue":"17","key":"10.1016\/j.tranon.2025.102611_bib0072","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/sj.onc.1204303","article-title":"p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53","volume":"20","author":"Lindstr\u00f6m","year":"2001","journal-title":"Oncogene,"},{"key":"10.1016\/j.tranon.2025.102611_bib0073","article-title":"Burkitt lymphomas evolve to escape dependencies on Epstein-Barr virus","volume":"10","author":"Hutcheson","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.tranon.2025.102611_bib0074","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fmicb.2017.00229","article-title":"Unveiling another missing piece in EBV-driven lymphomagenesis: eBV-encoded MicroRNAs expression in EBER-negative Burkitt lymphoma cases","volume":"8","author":"Mundo","year":"2017","journal-title":"Front. Microbiol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102611_bib0075","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/ijc.27893","article-title":"Epstein-Barr virus-induced epigenetic alterations following transient infection","volume":"132","author":"Queen","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.tranon.2025.102611_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/v9110341","article-title":"Epstein-barr virus hijacks DNA damage response transducers to orchestrate its life cycle","volume":"9","author":"Hau","year":"2017","journal-title":"Viruses."},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0077","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1128\/JVI.00053-07","article-title":"The ATM\/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2\/M cell cycle block","volume":"81","author":"Choudhuri","year":"2007","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102611_bib0078","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/sj.onc.1207253","article-title":"The EBNA-3 gene family proteins disrupt the G2\/M checkpoint","volume":"23","author":"Krauer","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.tranon.2025.102611_bib0079","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/cdd.2017.150","article-title":"Coordinated repression of BIM and PUMA by Epstein\u2013Barr virus latent genes maintains the survival of Burkitt lymphoma cells","volume":"25","author":"Fitzsimmons","year":"2018","journal-title":"Cell Death Differ."},{"issue":"14","key":"10.1016\/j.tranon.2025.102611_bib0080","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1182\/blood-2010-02-268003","article-title":"Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma","volume":"116","author":"Richter-Larrea","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001236","article-title":"Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1","volume":"6","author":"Kvansakul","year":"2010","journal-title":"PLoS. Pathog."},{"issue":"2","key":"10.1016\/j.tranon.2025.102611_bib0082","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.yexmp.2015.03.006","article-title":"Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis","volume":"98","author":"Robaina","year":"2015","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0083","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1158\/2643-3230.BCD-24-0240","article-title":"DNA methylation epitypes of Burkitt lymphoma with distinct molecular and clinical features","volume":"6","author":"Thomas","year":"2025","journal-title":"Blood Cancer Discov."},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0084","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.70042","article-title":"Subtyping Burkitt lymphoma by DNA methylation","volume":"64","author":"Glaser","year":"2025","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.tranon.2025.102611_bib0085","article-title":"The status and prospects of epigenetics in the treatment of lymphoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102611_bib0086","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/s41375-025-02612-8","article-title":"The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells","volume":"39","author":"Mieland","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2025.102611_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149369","article-title":"Epigenetic activation of PTEN by valproic acid inhibits PI3K\/AKT signaling and Burkitt lymphoma cell growth","volume":"950","author":"Li","year":"2025","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0088","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/his.14798","article-title":"Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications","volume":"81","author":"Baptista","year":"2022","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.tranon.2025.102611_bib0089","doi-asserted-by":"crossref","first-page":"15678","DOI":"10.1002\/jcp.28219","article-title":"HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood","volume":"234","author":"Sall","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"5","key":"10.1016\/j.tranon.2025.102611_bib0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.it.2011.03.003","article-title":"Complex regulation and function of activation-induced cytidine deaminase","volume":"32","author":"Stavnezer","year":"2011","journal-title":"Trends. Immunol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102611_bib0091","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.it.2015.07.003","article-title":"AID targeting: old mysteries and new challenges","volume":"36","author":"Chandra","year":"2015","journal-title":"Trends. Immunol."},{"issue":"9","key":"10.1016\/j.tranon.2025.102611_bib0092","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.20030275","article-title":"Constitutive expression of AID leads to tumorigenesis","volume":"197","author":"Okazaki","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0093","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/ijc.29127","article-title":"AID expression in peripheral blood of children living in a malaria holoendemic region is associated with changes in B cell subsets and Epstein-Barr virus","volume":"136","author":"Wilmore","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0094","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2015.07.019","article-title":"Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma","volume":"162","author":"Robbiani","year":"2015","journal-title":"Cell,"},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.20160120","article-title":"Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells","volume":"213","author":"Kalchschmidt","year":"2016","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.tranon.2025.102611_bib0096","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004170","article-title":"A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis","volume":"10","author":"Torgbor","year":"2014","journal-title":"PLoS. Pathog."},{"issue":"8","key":"10.1016\/j.tranon.2025.102611_bib0097","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/eji.202249820","article-title":"Epstein-Barr virus and malaria upregulate AID and APOBEC3 enzymes, but only AID seems to play a major mutagenic role in Burkitt lymphoma","volume":"52","author":"Summerauer","year":"2022","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0098","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0099","first-page":"609","article-title":"Epstein-Barr virus and Burkitt lymphoma","volume":"33","author":"Rowe","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102611_bib0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.7351","article-title":"Mosquito bed net use and burkitt lymphoma incidence in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"7","author":"Schmit","year":"2024","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0101","first-page":"166","article-title":"Burkitt's lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem","year":"2007","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.tranon.2025.102611_bib0102","series-title":"StatPearls","article-title":"Plasmodium falciparum Malaria","author":"Zekar","year":"2023"},{"issue":"12","key":"10.1016\/j.tranon.2025.102611_bib0103","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/infdis\/jit096","article-title":"Primary Epstein-Barr virus infection: impact of age at acquisition, coinfection, and viral load","volume":"207","author":"Balfour","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.tranon.2025.102611_bib0104","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1016\/S2352-3026(24)00351-X","article-title":"Diagnosis and treatment of Burkitt lymphoma in adults: clinical practice guidelines from ERN-EuroBloodNet","volume":"12","author":"Ribrag","year":"2025","journal-title":"Lancet Haematol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0105","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood.2019004099","article-title":"The treatment of Burkitt lymphoma in adults","volume":"137","author":"Crombie","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2025.102611_bib0106","article-title":"Burkitt Lymphoma","author":"Naing","year":"2025","journal-title":"StatPearls"},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0107","article-title":"Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102611_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107057","article-title":"Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma","volume":"208","author":"El Omari","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"19","key":"10.1016\/j.tranon.2025.102611_bib0109","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.7150\/thno.26823","article-title":"EBNA1-targeted inhibitors: novel approaches for the treatment of Epstein-Barr virus-associated cancers","volume":"8","author":"Jiang","year":"2018","journal-title":"Theranostics."},{"issue":"3","key":"10.1016\/j.tranon.2025.102611_bib0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.123.001583","article-title":"Chidamide induces Epstein-Barr Virus (EBV) lytic infection and acts synergistically with Tenofovir to eliminate EBV-positive Burkitt lymphoma","volume":"387","author":"Xu","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tranon.2025.102611_bib0111","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101260","article-title":"Therapeutic approaches to Epstein-Barr virus cancers","volume":"56","author":"Soldan","year":"2022","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102611_bib0112","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12967-025-06188-w","article-title":"Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6","key":"10.1016\/j.tranon.2025.102611_bib0113","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/bjh.19425","article-title":"Targeted therapy in Burkitt lymphoma: small molecule inhibitors under investigation","volume":"204","author":"Atallah-Yunes","year":"2024","journal-title":"Br. J. Haematol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T15:01:50Z","timestamp":1773846110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":113,"alternative-id":["S1936523325003420"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102611","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular variations in Burkitt lymphoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102611"}}